Medical Forum Monthly
The Role of Soluble Tumor Necrosis Factor Receptor II as a Prognostic Marker in Severe COVID-19
By Muayad AL-dulaimi, Saleh A.H and Mohammad Mutlag Salih.
Abstract
Objective
To investigate the clinical disease characteristics and standard laboratory parameters in relation to specific cytokine biomarkers associated with COVID-19 sequelae and to elucidate their correlations with disease severity, respiratory support requirements, and patient outcomes Study Design: Case control studyPlace and Duration of Study: This study was conducted at the Diyala, Iraq, from 1st December 2024 to 30th April 2025.